AMZN
Amazon.com, Inc.
AMZN has the edge over BKE overall, supported by stronger valuation and stronger modeled upside.
BKE
The Buckle, Inc.
BKE offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
BKE's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BKE in the historical PE scenario, which offers more potential upside but is not a forecast.
BKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $30.61 | -30% |
| Fair | 9.8x | $42.53 | -3.2% |
| Current | 10x | $43.94 | — |
| Forward | 11x | $43.94 | — |
| Expensive | 13x | $56.38 | +28% |
Historical ranges are pointers, not guarantees.
BKE's PE is in its fair range at 10x. On analysts' estimates for next year's earnings, today's price would be 11x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over BKE on the outlook, with more favorable earnings and profitability expectations.
BKE Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect BKE's revenue to grow, but its profitability to weaken.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BKE on earnings, with more consistent year-over-year improvement.
BKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.10 | -5.4% |
| Q3 2026 | $4.34 | +8.2% |
| Q2 2026 | $4.36 | +12% |
| Q1 2026 | $4.14 | +6.4% |
| Q4 2025 | $4.09 | +4.1% |
| Q3 2025 | $4.01 | -2% |
| Q2 2025 | $3.90 | -7.8% |
| Q1 2025 | $3.89 | -12% |
| Q4 2024 | $3.93 | -14% |
BKE earned $4.34 per share over the past year, up 8.2% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
BKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $319.8M | +4.6% |
| Q2 2026 | $288.7M | +6.1% |
| Q1 2026 | $399.1M | +5.3% |
| Q4 2025 | $320.8M | +9.3% |
| Q3 2025 | $305.7M | +8.3% |
| Q2 2025 | $272.1M | +3.7% |
| Q1 2025 | $379.2M | -0.8% |
| Q4 2024 | $293.6M | -3.2% |
BKE's revenue has grown year over year for six quarters in a row: $320M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | -1 points |
| Q2 2026 | 21% | +4.6 points |
| Q1 2026 | 25% | -0.2 points |
| Q4 2025 | 19% | +0.4 points |
| Q3 2025 | 18% | +1.3 points |
| Q2 2025 | 16% | -0.1 points |
| Q1 2025 | 25% | +0.1 points |
| Q4 2024 | 19% | -2.6 points |
BKE has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16.9M | -64% |
| Q2 2026 | $34.7M | +77% |
| Q1 2026 | $101.4M | -8.6% |
| Q4 2025 | $38.4M | +14% |
| Q3 2025 | $46.4M | +28% |
| Q2 2025 | $19.6M | +2.7% |
| Q1 2025 | $111M | +11% |
| Q4 2024 | $33.6M | -37% |
BKE has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +11K shares |
| 1 year | +0.8% | +380K shares |
| 3 years | +2.3% | +1.1M shares |
| 5 years | +3.4% | +1.7M shares |
| Available history | +4.5% | +2.2M shares |
BKE has 51M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | $372,000 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
BKE has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 53.3 | Neutral |
BKE's weekly RSI is 47 (neutral) and its Stochastic is 53 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BKE PE vs Consumer Cyclical Sector
| Metric | BKE | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 18x | 44% below |
| PE % | 55 | 47 | 8 pts above |
BKE has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BKE on trend strength, trading above more of its moving averages.
BKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.3 | 0.9% below |
| 20 week MA | $43.5 | 1.1% above |
| 50 week MA | $48.2 | 8.9% below |
| 100 week MA | $48.0 | 8.4% below |
| 200 week MA | $43.4 | 1.3% above |
BKE's trend is mixed: it's above two of its five weekly moving averages, and 1.3% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BKE on returns for 2026, with the stronger performance.
BKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.7 | $30.1 | +13% |
| 2021 | $30.1 | $40.9 | +36% |
| 2022 | $40.9 | $45.2 | +11% |
| 2023 | $45.2 | $47.5 | +5.1% |
| 2024 | $47.5 | $51.5 | +8.4% |
| 2025 | $51.5 | $54.3 | +5.4% |
| 2026 YTD | $54.3 | $43.9 | -19% |
BKE has finished every year since 2020 higher, and it's down 19% so far in 2026.